RAI1 and obesity due to melanocortin 4 receptor deficiency: In evaluating the clinical features of SMS in relation to molecular results, we found that a high BMI and obesity are characteristic of the de novo RAI1 variant cases (4/5), as previously reported (6/9 or 67%) [3].